Antihelminthic Therapy Combined With Antimony in the Treatment of Cutaneous Leishmaniasis
Status:
Completed
Trial end date:
2008-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this project is to investigate the efficacy of early, empiric anti-helminthic
therapy combined with standard pentavalent antimony in the treatment of subjects co-infected
with helminths and cutaneous leishmaniasis caused by L. brasiliensis. The study hypothesis is
that early intervention with antihelminthic therapy will improve response rates to antimony
in subjects with cutaneous leishmaniasis.